GlaxoSmithKline

Venture Capital

GSK, a global biopharma leader, invests through corporate venture arms like SR One and Action Potential Venture Capital in biotech, bioelectronics, and health innovations.

Brentford, United Kingdom · 6+ investments · 3 portfolio companies

Early Stage
Growth
Biotech
Healthcare
Headquarters
Brentford, United Kingdom
Founded
2000
Website
gsk.com
Portfolio Companies
3
Total Investments
6
Last Investment
Feb 2024
Geographic Focus
Global

Investment Thesis

Investing in pioneering bioelectronic medicines, technologies, and biotech to advance science in immunology, oncology, and infectious diseases.

GlaxoSmithKline is a Venture Capital firm based in Brentford, United Kingdom. It has made 6 investments, including SuperGen, Lyell Immunopharma and Nkarta Therapeutics. Focus areas include Biotech and Healthcare.

Portfolio3

Co-investors21

Sign up to view co-investors

21 co-investors across 22 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×14 · Private Equity ×3 · Corporate VC ×2 · 3 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

GlaxoSmithKline on Indexed.vc
<a href="https://indexed.vc/investors/glaxosmithkline"><img src="https://indexed.vc/api/badge/investor/glaxosmithkline" alt="GlaxoSmithKline on Indexed.vc" width="260" height="76" /></a>